@trishmcbrown's GHK-Cu injection tips, fact-checked

What did @trishmcbrown actually say?

Over two weeks of self-injecting GHK-Cu subcutaneously, @trishmcbrown shared five technique tips her provider gave her: push a small amount of air into the vial before drawing, let the solution reach room temperature for about 15 minutes, inject into posterior hip fat rather than the lateral hip, let the alcohol prep site dry completely before inserting the needle, and inject slowly. She's careful to frame all of this as personal experience, saying "I am no expert" and crediting her provider throughout. That kind of transparency is worth noting, because it's rarer than it should be on peptide TikTok.

Her primary outcome claim is that these steps eliminated the burning, welting, stinging, and redness that she'd heard others report. She's two weeks in, acknowledges possible skin reactions may still come, and invites pushback. The video is practical, not promotional. That doesn't make everything in it medically sound, but it's a reasonable baseline.

Does the science back this up?

Some of it, yes. The alcohol-drying tip is the most evidence-supported of the five. Injecting through wet alcohol is a real problem: residual isopropyl alcohol introduced subcutaneously causes a localized chemical irritant response. This is well-documented in nursing and diabetes care literature. Cho et al. (2017, Journal of Diabetes Science and Technology) confirmed that allowing the site to dry before insulin injection reduces injection-site pain. The principle applies directly here.

The slow-injection tip also has support. Rapid subcutaneous injection increases tissue pressure transiently, which activates pain receptors. A slower injection rate distributes the solution more gradually. This is supported by work on subcutaneous drug delivery mechanics, including Gradel et al. (2018, Current Drug Delivery).

The air-into-vial technique is standard practice for drawing from rubber-stoppered vials, used in clinical settings to equalize pressure. It's not a safety shortcut. Room temperature warming before injection is a common recommendation for viscous solutions, though the evidence base is mostly from insulin research rather than peptide-specific data.

What did they get wrong (or right)?

The injection-site location advice deserves closer examination. Recommending the posterior hip fat, what she calls "love handles" or "hip fat," is reasonable as a subcutaneous site. However, she injects seven days a week, alternating only between two sides. That's a limited rotation. Subcutaneous tissue used repeatedly without adequate rest develops lipohypertrophy, a hardened, scarred fat tissue that impairs absorption. This is well-established in insulin therapy literature (Blanco et al., 2013, Diabetes Care) and the same mechanism applies to any repeated subcutaneous injection.

She also mentions no issues after two weeks and implies the tips are the reason. That may be partly true, but GHK-Cu injection reactions appear to vary by formulation, concentration, and excipient composition, not just technique. Two weeks is a short observation window. Her experience is real, but it's n=1 and shouldn't be read as a general outcome prediction.

What she got clearly right: she never claims GHK-Cu treats a disease, doesn't recommend a dose, and repeatedly defers to her provider. That's the floor of responsible self-injection content, and she clears it.

What should you actually know?

GHK-Cu (copper peptide GHK-Cu) has a legitimate research base, primarily around wound healing, collagen synthesis modulation, and anti-inflammatory signaling. Pickart et al. (2015, Journal of Aging Science) summarized its mechanisms, including upregulation of tissue remodeling pathways. But most of this research is in vitro or animal-based. Human clinical trial data for subcutaneous systemic use in the wellness context, as opposed to topical wound care, is thin.

The injection tips in this video are largely drawn from established subcutaneous injection best practices, not from GHK-Cu-specific research. That's fine as a practical matter, but it means the tips are generalizable technique, not peptide-specific insight. Anyone injecting any subcutaneous peptide should follow the same principles. The bigger question, whether subcutaneous GHK-Cu produces the systemic effects people are seeking, remains less settled than the TikTok peptide community tends to acknowledge.

If you're considering peptide therapy, these technique tips are a reasonable starting point for a conversation with a licensed provider. They are not a substitute for one.